Continuous Manufacturing of Oral Solid Dosage Forms
Date:
2024/04/16
to 2024/04/18
Location:
Portugal
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Commitment to partnership and joint innovation for cell and gene therapies
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Executiva, 23 February 2026